NovaBay Pharmaceuticals Reports Second Quarter 2022 Financial Results
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and six months ended June 30, 2022 and provides a business update. Financial results for the first six months of 2022 include the operations of the DERMAdoctor business, which was acquired on November 5, 2021. “The strategy to expand and diversify our portfolio of high-quality products is paying off with product revenue increasing 43% over the prior year. We are also